Share on StockTwits

Becton, Dickinson and (NYSE:BDX) has been given an average rating of “Hold” by the sixteen analysts that are presently covering the stock, Analyst Ratings.Net reports. Two equities research analysts have rated the stock with a sell recommendation, four have given a hold recommendation and six have assigned a buy recommendation to the company. The average twelve-month target price among brokers that have updated their coverage on the stock in the last year is $112.90.

Becton, Dickinson and (NYSE:BDX) opened at 118.06 on Monday. Becton, Dickinson and has a one year low of $96.73 and a one year high of $120.66. The stock has a 50-day moving average of $118.2 and a 200-day moving average of $115.. The company has a market cap of $22.648 billion and a price-to-earnings ratio of 23.91.

Becton, Dickinson and (NYSE:BDX) last announced its earnings results on Thursday, July 31st. The company reported $1.65 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.67 by $0.02. The company had revenue of $2.16 billion for the quarter, compared to the consensus estimate of $2.14 billion. During the same quarter in the previous year, the company posted $1.58 earnings per share. The company’s revenue for the quarter was up 5.1% on a year-over-year basis. On average, analysts predict that Becton, Dickinson and will post $6.25 earnings per share for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Tuesday, September 30th. Stockholders of record on Tuesday, September 9th will be paid a dividend of $0.545 per share. This represents a $2.18 annualized dividend and a dividend yield of 1.85%. The ex-dividend date is Friday, September 5th.

A number of analysts have recently weighed in on BDX shares. Analysts at JPMorgan Chase & Co. reiterated an “underweight” rating on shares of Becton, Dickinson and in a research note on Friday, August 1st. They now have a $115.00 price target on the stock, up previously from $111.00. Separately, analysts at RBC Capital raised their price target on shares of Becton, Dickinson and from $113.00 to $116.00 in a research note on Friday, August 1st. Finally, analysts at Leerink Swann raised their price target on shares of Becton, Dickinson and from $117.00 to $120.00 in a research note on Friday, August 1st.

Becton Dickinson and Co is a global medical technology company engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.